Clinical Trials Directory

Trials / Conditions / Obesity/Overweight

Obesity/Overweight

16 registered clinical trials studyying Obesity/Overweight5 currently recruiting.

StatusTrialSponsorPhase
RecruitingFast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight
NCT07141342
Jonathan PearlmanN/A
RecruitingtDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment
NCT07112521
University of HelsinkiN/A
RecruitingStudy of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver
NCT07144098
Gan & Lee Pharmaceuticals.Phase 1
Active Not RecruitingMachine Learning for Estimating Cardiorespiratory Fitness in Patients With Obesity
NCT07011108
Sykehuset i Vestfold HF
RecruitingThis is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179
AstraZenecaPhase 2
CompletedA Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function
NCT06938529
Vincentage Pharma Co., LtdPhase 1
RecruitingStudy of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Fun
NCT07141030
Gan & Lee Pharmaceuticals.Phase 1
Active Not RecruitingA Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Su
NCT06728124
Gan & Lee Pharmaceuticals.Phase 3
CompletedEffect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
NCT06621017
Rose Pharma IncPhase 2
CompletedEffect of Food Temperature and Diet Composition on Satiety, Satiety Hormones, Chewing Time and Neuronal Activi
NCT05822167
Khyber Medical University PeshawarN/A
CompletedEfficacy and Safety of ALT-801 in the Treatment of Obesity
NCT05295875
Altimmune, Inc.Phase 2
Active Not RecruitingPharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
NCT04605081
Yale UniversityPhase 2 / Phase 3
Active Not RecruitingPharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage
NCT04599504
Yale UniversityPhase 2 / Phase 3
CompletedWeight Regain Treatment Post-Bariatric Surgery
NCT04662801
Yale UniversityPhase 2 / Phase 3
Active Not RecruitingPharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
NCT04599478
Yale UniversityPhase 2 / Phase 3
UnknownDiet Therapy Versus Prescriptive Educational Group Intervention in Overweight / Obese Patients at First Episod
NCT02323802
Fondazione IRCCS Policlinico San Matteo di PaviaN/A